16-31001559-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_052874.5(STX1B):c.75G>A(p.Arg25Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,613,030 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.000020   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.000018   (  0   hom.  ) 
Consequence
 STX1B
NM_052874.5 synonymous
NM_052874.5 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.583  
Publications
0 publications found 
Genes affected
 STX1B  (HGNC:18539):  (syntaxin 1B) The protein encoded by this gene belongs to a family of proteins thought to play a role in the exocytosis of synaptic vesicles. Vesicle exocytosis releases vesicular contents and is important to various cellular functions. For instance, the secretion of transmitters from neurons plays an important role in synaptic transmission. After exocytosis, the membrane and proteins from the vesicle are retrieved from the plasma membrane through the process of endocytosis. Mutations in this gene have been identified as one cause of fever-associated epilepsy syndromes. A possible link between this gene and Parkinson's disease has also been suggested. [provided by RefSeq, Jan 2015] 
STX1B Gene-Disease associations (from GenCC):
- generalized epilepsy with febrile seizures plusInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- generalized epilepsy with febrile seizures plus, type 9Inheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36). 
BP6
Variant 16-31001559-C-T is Benign according to our data. Variant chr16-31001559-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 475341.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=-0.583 with no splicing effect.
BS2
High AC in GnomAdExome4 at 26 AD gene. 
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| STX1B | ENST00000215095.11 | c.75G>A | p.Arg25Arg | synonymous_variant | Exon 2 of 10 | 1 | NM_052874.5 | ENSP00000215095.5 | ||
| STX1B | ENST00000565419.2 | c.75G>A | p.Arg25Arg | synonymous_variant | Exon 2 of 9 | 2 | ENSP00000455899.1 | 
Frequencies
GnomAD3 genomes  0.0000197  AC: 3AN: 152150Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
3
AN: 
152150
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0000280  AC: 7AN: 250336 AF XY:  0.0000295   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
7
AN: 
250336
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.0000178  AC: 26AN: 1460880Hom.:  0  Cov.: 31 AF XY:  0.0000165  AC XY: 12AN XY: 726768 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
26
AN: 
1460880
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
12
AN XY: 
726768
show subpopulations 
African (AFR) 
 AF: 
AC: 
0
AN: 
33468
American (AMR) 
 AF: 
AC: 
0
AN: 
44670
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26096
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39696
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
86238
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
52888
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5608
European-Non Finnish (NFE) 
 AF: 
AC: 
26
AN: 
1111866
Other (OTH) 
 AF: 
AC: 
0
AN: 
60350
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.479 
Heterozygous variant carriers
 0 
 2 
 4 
 5 
 7 
 9 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000197  AC: 3AN: 152150Hom.:  0  Cov.: 32 AF XY:  0.0000135  AC XY: 1AN XY: 74330 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
3
AN: 
152150
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
1
AN XY: 
74330
show subpopulations 
African (AFR) 
 AF: 
AC: 
1
AN: 
41430
American (AMR) 
 AF: 
AC: 
0
AN: 
15274
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5194
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4826
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10612
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
316
European-Non Finnish (NFE) 
 AF: 
AC: 
2
AN: 
68024
Other (OTH) 
 AF: 
AC: 
0
AN: 
2090
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.425 
Heterozygous variant carriers
 0 
 0 
 1 
 1 
 2 
 2 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:1 
Jun 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
STX1B: BP4, BP7 -
Generalized epilepsy with febrile seizures plus, type 9    Benign:1 
Oct 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.